Patents by Inventor Dennis R. Voelker

Dennis R. Voelker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273681
    Abstract: The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.
    Type: Application
    Filed: February 10, 2022
    Publication date: September 1, 2022
    Inventor: Dennis R. VOELKER
  • Publication number: 20220241302
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: September 13, 2021
    Publication date: August 4, 2022
    Inventors: Dennis R. Voelker, Mari Numata-Nakamura
  • Patent number: 11278556
    Abstract: The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: March 22, 2022
    Assignee: National Jewish Health
    Inventor: Dennis R. Voelker
  • Publication number: 20200297744
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: December 5, 2019
    Publication date: September 24, 2020
    Inventors: Dennis R. Voelker, Mari Numata-Nakamura
  • Publication number: 20200179413
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: December 5, 2019
    Publication date: June 11, 2020
    Inventors: Dennis R. Voelker, Mari Numata-Nakamura
  • Patent number: 10532066
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Grant
    Filed: December 4, 2017
    Date of Patent: January 14, 2020
    Assignee: National Jewish Health
    Inventors: Dennis R. Voelker, Mari Numata-Nakamura
  • Publication number: 20200009165
    Abstract: The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 9, 2020
    Applicant: National Jewish Health
    Inventor: Dennis R. VOELKER
  • Publication number: 20180177807
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: December 4, 2017
    Publication date: June 28, 2018
    Inventors: Dennis R. Voelker, Mari Numata-Nakamura
  • Patent number: 9861649
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: January 9, 2018
    Assignee: National Jewish Health
    Inventor: Dennis R. Voelker
  • Publication number: 20150150891
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: June 27, 2014
    Publication date: June 4, 2015
    Inventor: Dennis R. Voelker
  • Patent number: 8796243
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Grant
    Filed: January 2, 2013
    Date of Patent: August 5, 2014
    Assignee: National Jewish Health
    Inventor: Dennis R. Voelker
  • Patent number: 8367643
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: February 5, 2013
    Assignee: National Jewish Health
    Inventor: Dennis R. Voelker
  • Publication number: 20080242640
    Abstract: The invention generally relates to methods to inhibit inflammation or pathogen infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one anionic lipid or compositions comprising at least one anionic lipid to an individual. The invention further relates to compositions comprising randomly mixed surfactant lipids and methods to produce the compositions.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 2, 2008
    Applicant: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
    Inventor: Dennis R. Voelker